Unable to load price data. Sorry.

¯\_(ツ)_/¯

Kendle International, Inc. (NASDAQ:KNDL.DL)

CAPS Rating: No stars

The Company is a global clinical research organization that provides a range of Phase I-IV global clinical development services to the biopharmaceutical industry.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:KNDL.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Jeffreyw (25.09)
Submitted October 25, 2010

Should benefit from an industry fat with companies that need clinical trials for newly developed treatments.

dmgchess (47.06)
Submitted February 28, 2008

Although the biopharmaceutical services industry looks strong going forward, KNDL has a lower ROE (5.5%) than I'm happy with. Their decision to take on $198 million in debt in 2006 is worrying. This move raised their current liabilities to a level… More

NASDAQ:KNDL.DL VS S&P 500 (SPY)

NASDAQ:KNDL.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about KNDL.DL.

No one has written a Pitch for KNDL.DL stock yet. Tell us why you think KNDL.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in KNDL.DL.

No players have picked KNDL.DL yet. Tell us why you think KNDL.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackLadenburg < 20 11/5/2008 Outperform NS $25.55 -14.09% -14.54% +0.45 4/16/2009 @ $21.95 0 Comment
TrackLadenburg < 20 7/2/2008 Outperform NS $36.16 +36.50% -3.25% +39.75 9/19/2008 @ $49.36 0 Comment
TrackBroadpointAmTech < 20 3/28/2008 Outperform NS $45.11 -66.23% -0.77% -65.46 7/12/2011 @ $15.24 0 Comment
TrackFirstAnalys 87.14 2/26/2008 Outperform NS $42.42 -64.09% -3.66% -60.43 7/12/2011 @ $15.24 0 Comment
TrackJefferies 76.36 2/26/2008 Outperform NS $41.70 -78.68% -37.05% -41.64 4/27/2009 @ $8.89 0 Comment
TrackSusquehanna 88.72 12/5/2007 Outperform NS $43.34 -10.91% -4.83% -6.08 6/5/2008 @ $38.61 0 Comment
TrackWellsFargo 86.91 11/28/2007 Outperform NS $41.96 -63.69% -8.47% -55.22 7/12/2011 @ $15.24 0 Comment
TrackUBS 91.16 11/20/2007 Outperform NS $41.92 -63.66% -8.37% -55.29 7/12/2011 @ $15.24 0 Comment
TrackRWBaird 89.13 11/1/2007 Outperform NS $41.94 -74.13% -45.70% -28.43 4/21/2009 @ $10.85 0 Comment
TrackUBS 91.16 9/12/2007 Outperform NS $39.02 +1.77% +2.70% -0.93 10/25/2007 @ $39.71 0 Comment
TrackJefferies 76.36 6/15/2007 Outperform NS $35.08 +29.70% -16.31% +46.02 1/22/2008 @ $45.50 0 Comment
TrackJefferies 76.36 8/29/2006 Outperform NS $26.90 +33.53% +11.99% +21.54 2/20/2007 @ $35.92 0 Comment

Advertisement